Objective: Fibrosis plays an important role in heart failure (HF) and other diseases that occur more frequently with increasing age. Depression is associated with an increased risk of heart failure and other age-related diseases. This study examined the association between depressive symptoms and fibrosis markers in adults aged 65 years and above. Methods: Fibrosis markers and depressive symptoms were assessed in 870 participants (age = 80.9 ± 5.9 yrs, 49% women) using a case-control design based on heart failure status (307 HF patients and 563 ageand sex-matched controls, of whom 284 with CVD risk factors (hypertension, diabetes mellitus, or hypercholesterolemia) and 279 controls without these CVD risk factors). Fibrosis markers were procollagen type I (PIP), type I collagen (CITP), and procollagen type III (PIIINP). Inflammation markers included C-reactive protein, white blood cell counts and fibrinogen. Depression was assessed using the Center for Epidemiological Studies-Depression (CES-D) scale using a previously validated cut-off point for depression (CES-D P 8). Covariates included demographic and clinical variables. also elevated in depressed participants (CRP, p = 0.014; WBC, p = 0.075; fibrinogen, p = 0.074), but these inflammation markers did not account for the relationship between depression and fibrosis markers. Conclusions: Depression is associated with elevated fibrosis markers and may therefore adversely affect heart failure and other age-related diseases in which extra-cellular matrix formation plays a pathophysiological role.
a b s t r a c t
Objective: Fibrosis plays an important role in heart failure (HF) and other diseases that occur more frequently with increasing age. Depression is associated with an increased risk of heart failure and other age-related diseases. This study examined the association between depressive symptoms and fibrosis markers in adults aged 65 years and above. Methods: Fibrosis markers and depressive symptoms were assessed in 870 participants (age = 80.9 ± 5.9 yrs, 49% women) using a case-control design based on heart failure status (307 HF patients and 563 ageand sex-matched controls, of whom 284 with CVD risk factors (hypertension, diabetes mellitus, or hypercholesterolemia) and 279 controls without these CVD risk factors). Fibrosis markers were procollagen type I (PIP), type I collagen (CITP), and procollagen type III (PIIINP). Inflammation markers included C-reactive protein, white blood cell counts and fibrinogen. Depression was assessed using the Center for Epidemiological Studies-Depression (CES-D) scale using a previously validated cut-off point for depression (CES-D P 8). Covariates included demographic and clinical variables. also elevated in depressed participants (CRP, p = 0.014; WBC, p = 0.075; fibrinogen, p = 0.074), but these inflammation markers did not account for the relationship between depression and fibrosis markers. Conclusions: Depression is associated with elevated fibrosis markers and may therefore adversely affect heart failure and other age-related diseases in which extra-cellular matrix formation plays a pathophysiological role.
Ó 2009 Elsevier Inc. All rights reserved.
Introduction
Depression is a risk factor for adverse health outcomes, particularly for diseases that occur more frequently with increasing age including heart failure (Rutledge et al., 2006; Williams et al., 2002) and cardiovascular disease (CVD)-related morbidity and mortality {Nicholson et al., 2006; Wulsin and Singal, 2003; Rozanski et al., 2005} . The pathophysiological pathways by which depression adversely affects health outcomes involve both biological processes (e.g., neurohormonal dysregulation, inflammation, blood coagulation, and platelet activation) as well as behavioural factors (e.g., smoking, poor diet, sedentary lifestyle, and medication non-adherence) (Rozanski et al., 2005; Whooley et al., 2008; Kop and Gottdiener, 2005; Lesperance and Frasure-Smith, 2000) . Because there is overlap in the symptoms of depression and age-related physical disorders (e.g., fatigue, lack of energy, and sleep disturbances) physical symptoms are likely to confound the relationship between depression and disease progression. Investigation of fibrosis markers provides unique opportunities to examine the pathophysiological consequences of depression in age-related diseases in which extra-cellular matrix formation plays a primary role while minimizing potential confounding by physical symptoms.
Fibrosis contributes to cardiovascular disease progression in general and heart failure in particular. Myocardial fibrosis and
